Key facts
- Notable investors include Anthill Ventures, 3T Invest.
- Status: Privately Held (backing).
Investors
2- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Super Human
- ·The full record, as it builds
Funding rounds
No funding rounds for Super Human are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Super Human
Organizer of exclusive gatherings focused on exploring cutting-edge science, technology, and strategies for extending human longevity. The company hosts events that bring together leading experts and innovators to discuss advancements in human evolution and longevity and to deep dive into cutting-edge therapies, breakthrough innovations, and bold policies designed to propel humanity forward, enabling users to aim at accelerating the development of technologies and strategies that enhance human life.
- Sector
- Healthcare
- HQ
- London, United Kingdom
- Founded
- 2025
- Employees
- 10
- Website
- superhuman.net/
- Ownership
- Privately Held (backing)
Super Human doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Super Human shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Super Human in its N-PORT filings yet. We sweep new filings monthly.